Neumann Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,227
| Closed | -$869K | – | 86 |
|
|
2026
Q1 | $869K | Hold |
7,227
| – | – | 0.26% | 67 |
|
|
2025
Q4 | $761K | Buy |
7,227
+442
| +7% | +$41.5K | 0.22% | 69 |
|
|
2025
Q3 | $569K | Buy |
6,785
+900
| +15% | +$74.1K | 0.17% | 75 |
|
|
2025
Q2 | $466K | Hold |
5,885
| – | – | 0.15% | 80 |
|
|
2025
Q1 | $528K | Hold |
5,885
| – | – | 0.18% | 77 |
|
|
2024
Q4 | $585K | Buy |
5,885
+1,000
| +20% | +$103K | 0.19% | 76 |
|
|
2024
Q3 | $555K | Sell |
4,885
-1,800
| -27% | -$214K | 0.18% | 73 |
|
|
2024
Q2 | $828K | Hold |
6,685
| – | – | 0.28% | 64 |
|
|
2024
Q1 | $882K | Buy |
6,685
+1,800
| +37% | +$222K | 0.31% | 63 |
|
|
2023
Q4 | $533K | Buy |
4,885
+120
| +3% | +$12.5K | 0.21% | 69 |
|
|
2023
Q3 | $491K | Hold |
4,765
| – | – | 0.21% | 68 |
|
|
2023
Q2 | $550K | Hold |
4,765
| – | – | 0.23% | 66 |
|
|
2023
Q1 | $507K | Hold |
4,765
| – | – | 0.22% | 65 |
|
|
2022
Q4 | $529K | Hold |
4,765
| – | – | 0.25% | 65 |
|
|
2022
Q3 | $410K | Buy |
4,765
+33
| +0.7% | +$2.95K | 0.21% | 72 |
|
|
2022
Q2 | $431K | Buy |
4,732
+50
| +1% | +$4.43K | 0.22% | 67 |
|
|
2022
Q1 | $384K | Buy |
4,682
+125
| +3% | +$9.86K | 0.16% | 71 |
|
|
2021
Q4 | $349K | Buy |
4,557
+100
| +2% | +$7.96K | 0.14% | 74 |
|
|
2021
Q3 | $335K | Buy |
4,457
+650
| +17% | +$49.4K | 0.15% | 74 |
|
|
2021
Q2 | $296K | Sell |
3,807
-183
| -5% | -$13.6K | 0.13% | 74 |
|
|
2021
Q1 | $293K | Hold |
3,990
| – | – | 0.14% | 71 |
|
|
2020
Q4 | $311K | Hold |
3,990
| – | – | 0.16% | 66 |
|
|
2020
Q3 | $316K | Hold |
3,990
| – | – | 0.18% | 63 |
|
|
2020
Q2 | $294K | Hold |
3,990
| – | – | 0.18% | 64 |
|
|
2020
Q1 | $293K | Hold |
3,990
| – | – | 0.21% | 63 |
|
|
2019
Q4 | $346K | Hold |
3,990
| – | – | 0.2% | 64 |
|
|
2019
Q3 | $320K | Sell |
3,990
-1,530
| -28% | -$123K | 0.2% | 66 |
|
|
2019
Q2 | $442K | Hold |
5,520
| – | – | 0.27% | 62 |
|
|
2019
Q1 | $438K | Hold |
5,520
| – | – | 0.28% | 62 |
|
|
2018
Q4 | $403K | Sell |
5,520
-419
| -7% | -$29.6K | 0.3% | 61 |
|
|
2018
Q3 | $402K | Hold |
5,939
| – | – | 0.24% | 63 |
|
|
2018
Q2 | $344K | Hold |
5,939
| – | – | 0.22% | 63 |
|
|
2018
Q1 | $309K | Buy |
5,939
+351
| +6% | +$19K | 0.2% | 64 |
|
|
2017
Q4 | $300K | Buy |
5,588
+105
| +2% | +$5.82K | 0.18% | 68 |
|
|
2017
Q3 | $335K | Buy |
5,483
+891
| +19% | +$54K | 0.21% | 67 |
|
|
2017
Q2 | $281K | Hold |
4,592
| – | – | 0.18% | 66 |
|
|
2017
Q1 | $278K | Hold |
4,592
| – | – | 0.18% | 67 |
|
|
2016
Q4 | $258K | Hold |
4,592
| – | – | 0.17% | 68 |
|
|
2016
Q3 | $274K | Hold |
4,592
| – | – | 0.18% | 68 |
|
|
2016
Q2 | $252K | Hold |
4,592
| – | – | 0.17% | 71 |
|
|
2016
Q1 | $232K | Hold |
4,592
| – | – | 0.15% | 74 |
|
|
2015
Q4 | $232K | Buy |
+4,592
| New | +$232K | 0.16% | 72 |
|
|
2015
Q3 | – | Sell |
-4,147
| Closed | -$225K | – | 79 |
|
|
2015
Q2 | $225K | Hold |
4,147
| – | – | 0.14% | 74 |
|
|
2015
Q1 | $227K | Hold |
4,147
| – | – | 0.14% | 79 |
|
|
2014
Q4 | $225K | Buy |
+4,147
| New | +$231K | 0.15% | 81 |
|
Other funds holding MRK
ECSS
Neumann Capital Management's MRK Position: Q2 2026 in Review
Neumann Capital Management sold out of Merck (MRK) in Q2 2026, closing a stake of 7,227 shares — an estimated $869K sold.
Neumann Capital Management first reported a position in MRK in Q4 2014 and held it in 45 quarters. The position peaked at $882K in Q1 2024. 1,802 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Neumann Capital Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Neumann Capital Management sold 7,227 Merck shares in Q2 2026, an estimated $869K.
- Neumann Capital Management first reported a position in Merck in Q4 2014 and held it in 45 quarters.
- Neumann Capital Management's Merck position peaked at $882K in Q1 2024.
- 1,802 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Neumann Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.